Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed.
Citrome LeslieRobert RisingerLavanya RajachandranHeather RobisonPublished in: Advances in therapy (2022)
gov, https://clinicaltrials.gov/ct2/show/NCT04276883 , NCT04276883.